Liye Pharmaceutical Co., Ltd. was first founded in 1969 and then restructured in 2001 with the initial investment of RMB 80 million as registered capital.
Of the total 130mu area occupation, the first-phase project of the new plant takes 50mu (with the construction completed in July, 2003. With the staff totaling 660 persons, Liye Pharmaceutical provides nationwide more than 40 products in varieties of tablets, pelletized granules, capsules, soft capsules, eye drop, enemas, raw material medicine and traditional Chinese medicine extract.
After the restructuring, Liye Pharmaceutical has got greatly improved under the leadership of Mr. Yu Shunan, general manager. With a long-term comprehensive development strategy involving human resource, enterprise image and management, and an elite team of the marketing, planning and managing, Liye Pharmaceutical had its economic efficiency tripled at the end of the year of its restructuring. We are exclusively providing Xin Le Kang Pian, a pure natural Chinese traditional machine to cure neurosis, Tearlo eye drops to relieve visual fatigue, Gui Mei Suan Pian (Cinametic acid tablets) with special efficacy to cure cholecystitis, Chaxinnamin Pian to abate asthma, Phacolin eye drops to cure cataract, and so on. As the first developer and manufacturer of Norfloxacin eye drops, Ciprofloxacin eye drops and artificial tears, Liye Pharmaceutical is determined to be a celebrated listed company with 3 years efforts relying on brand-new business idea, normative marketing management and high performance sales network.
Liye Pharmaceutical always lays its focus on quality of its products and has established a practical and effective quality assurance system, which has brought wide and high reputation to the products of Liye that are widely accepted by the market for stable quality, good price and remarkable efficacy, such as Chaxinnamin Pian with extremely high share of market and Weiyou Pian of Gold Prize for top sales in 2001.
Liye Pharmaceutical is always committed to making unremitting efforts to develop and promote high quality and high efficiency medicine with a view to peoples health. |
